Diagnostic test for diabetic kidney disease receives EU approval

02/11/2020 03:51 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Feb. 11 (CNA) A clinical test designed by a Taiwanese biotech company that predicts a patient's risk of diabetic kidney disease has been approved for sale in the European Union, the company said Tuesday.

The story is now in the CNA archive. Continue reading with a CNA archive membership.

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.